Two Consecutive Daily Trading Limits Hit by Xiangyu Medical: Brain-Computer Interface Products Not Yet Commercialized at Scale, Contributing Minimally to Revenue

Source: Securities Times

People's Finance News, January 6th: Two consecutive trading limitsSunnyou Medical(688626) disclosed a stock trading fluctuation announcement on January 6, stating that the capital market has recently shown high attention to concepts such as brain engineering and brain-computer interface, with significant increases in the stock prices of related sectors. The company currently focuses on non-invasive brain-computer interface technology, covering a full range of rehabilitation scenarios including occupational therapy, physical therapy, cognitive speech, and swallowing. This differs from the current international invasive brain-computer interface technology route. The company’s investment in brain-computer interface has formed a certain layout in terms of technology, products, and market channels, but bidding and sales have lagged behind. By the end of 2025, related products have not yet achieved scaled sales, and their revenue contribution remains relatively small.